Press releaseGlobe Newswire
BriaCell Therapeutics
BCTXZ · NASDAQ
$0.1402+$0.0002 (+0.14%)TodayMarket closed ·
No price history for this range.
BCTXZ key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 17.30K
- Volume
- 465
- Open price
- $0.14
- High today
- $0.1402
- Low today
- $0.1402
- 52 Week high
- $0.475
- 52 Week low
- $0.0551
BriaCell Therapeutics (BCTXZ) at a glance
BriaCell Therapeutics (BCTXZ) last traded at $0.1402, with a price-to-earnings ratio of 0.00.
Volume so far is 465 shares, below the average of 17.30K shares a day.
Over the past year BriaCell Therapeutics has ranged from $0.0551 to $0.475, and now sits 20% of the way up that range.
BCTXZ news
- Press releaseGlobe Newswire
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
- Press releaseGlobe Newswire
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
- Press releaseGlobe Newswire
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
- Press releaseGlobe Newswire
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
- Press releaseGlobe Newswire
BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer
- Press releaseGlobe Newswire
BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.